See also
ˇ Show More
AstraZeneca PLC, Common-Size Consolidated Statement of Financial Position, Assets
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
![]() |
Property, plant and equipment | 12.16 | 12.40 | 13.30 | 15.05 | 17.30 |
![]() |
Goodwill | 18.67 | 17.59 | 18.01 | 21.11 | 20.61 |
![]() |
Intangible assets | 20.78 | 21.66 | 22.26 | 26.34 | 23.91 |
![]() |
Derivative financial instruments | 0.65 | 0.58 | 0.48 | – | – |
![]() |
Other investments | 0.38 | 0.38 | 0.34 | 0.33 | 0.38 |
![]() |
Deferred tax assets | 2.87 | 2.63 | 2.35 | 2.64 | 2.18 |
![]() |
Non-current assets | 55.51% | 55.22% | 56.74% | 65.48% | 64.38% |
![]() |
Inventories | 3.51 | 3.00 | 3.19 | 3.50 | 4.42 |
![]() |
Trade receivables | 12.55 | 11.13 | 10.53 | 11.88 | 11.11 |
![]() |
Other receivables | 2.34 | 1.20 | 2.18 | 2.18 | 1.35 |
![]() |
Prepayments and accrued income | 1.68 | 1.66 | 1.33 | 1.46 | 1.45 |
![]() |
Trade and other receivables | 16.57% | 13.98% | 14.04% | 15.52% | 13.90% |
![]() |
Other investments | 8.04 | 2.64 | 2.70 | 0.83 | 0.37 |
![]() |
Derivative financial instruments | 0.05 | 0.02 | 0.04 | – | – |
![]() |
Income tax receivable | 2.00 | 5.42 | 5.23 | 5.52 | 4.69 |
![]() |
Cash and cash equivalents | 14.33 | 19.72 | 18.06 | 9.16 | 12.23 |
![]() |
Current assets | 44.49% | 44.78% | 43.26% | 34.52% | 35.62% |
![]() |
Total assets | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
May 19, 2012